 "Granules India Q2 net up 26% at Rs 40.83 crore")
Hyderabad-based Granules India Limited has reported a 26.49 per cent increase in consolidated net profit at Rs 40.83 crore for the quarter ended September, 2016 as compared with Rs 32.27 crore in the corresponding quarter previous year. The company's revenues stood at Rs 363.81 crore, an increase of 3 per cent over Rs 352.9 crore in the year ago period.
"We are focused to achieve our long term goals as we move ahead in the investment phase. Our APIs and PFI capacity enhancements within our base business and green field API facility in Vizag are both on track," Granules India chairman and managing director Krishna Prasad Chigurupati said.
During the quarter the US Food and Drug Administration (USFDA) has approved the company's ANDA for ibuprofen 200 mg orange tablets. The share of revenues from formulation division has also been growing, according to Prasad.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%